166 related articles for article (PubMed ID: 23009112)
41. TP53 mutations in canine brain tumors.
York D; Higgins RJ; LeCouteur RA; Wolfe AN; Grahn R; Olby N; Campbell M; Dickinson PJ
Vet Pathol; 2012 Sep; 49(5):796-801. PubMed ID: 22002975
[TBL] [Abstract][Full Text] [Related]
42. Comparative study of p53 gene and protein alterations in human astrocytic tumors.
Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR
J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161
[TBL] [Abstract][Full Text] [Related]
43. TP53 mutations and polymorphisms in primary myelofibrosis.
Raza S; Viswanatha D; Frederick L; Lasho T; Finke C; Knudson R; Ketterling R; Pardanani A; Tefferi A
Am J Hematol; 2012 Feb; 87(2):204-6. PubMed ID: 22052707
[TBL] [Abstract][Full Text] [Related]
44. TP53 alterations and clinical outcome in low grade astrocytomas.
Kraus JA; Bolln C; Wolf HK; Neumann J; Kindermann D; Fimmers R; Forster F; Baumann A; Schlegel U
Genes Chromosomes Cancer; 1994 Jun; 10(2):143-9. PubMed ID: 7520269
[TBL] [Abstract][Full Text] [Related]
45. Timing of p53 mutations during astrocytoma tumorigenesis.
del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M
Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922
[TBL] [Abstract][Full Text] [Related]
46. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.
Ohgaki H; Eibl RH; Schwab M; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; Wiestler OD; Kleihues P
Mol Carcinog; 1993; 8(2):74-80. PubMed ID: 8397797
[TBL] [Abstract][Full Text] [Related]
47. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
[TBL] [Abstract][Full Text] [Related]
48. Molecular markers relating to malignant progression in Grade II astrocytoma.
Yue WY; Yu SH; Zhao SG; Chen ZP
J Neurosurg; 2009 Apr; 110(4):709-14. PubMed ID: 19025355
[TBL] [Abstract][Full Text] [Related]
49. High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.
Saito K; Yokogami K; Maekawa K; Sato Y; Yamashita S; Matsumoto F; Mizuguchi A; Takeshima H
Hum Cell; 2021 Mar; 34(2):644-653. PubMed ID: 33454902
[TBL] [Abstract][Full Text] [Related]
50. From astrocytoma to glioblastoma: a clonal evolution study.
Yang F; Zou Y; Gong Q; Chen J; Li WD; Huang Q
FEBS Open Bio; 2020 May; 10(5):744-751. PubMed ID: 32069381
[TBL] [Abstract][Full Text] [Related]
51. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
[TBL] [Abstract][Full Text] [Related]
52. TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
Gillet E; Alentorn A; Doukouré B; Mundwiller E; van Thuijl HF; Reijneveld JC; Medina JA; Liou A; Marie Y; Mokhtari K; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
J Neurooncol; 2014 May; 118(1):131-9. PubMed ID: 24590827
[TBL] [Abstract][Full Text] [Related]
53. Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors.
Ganci F; Conti S; Fontemaggi G; Manciocco V; Donzelli S; Covello R; Muti P; Strano S; Blandino G; Spriano G
OMICS; 2011 Jun; 15(6):375-81. PubMed ID: 21348641
[TBL] [Abstract][Full Text] [Related]
54. High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors.
Hayes VM; Dirven CM; Dam A; Verlind E; Molenaar WM; Mooij JJ; Hofstra RM; Buys CH
Brain Pathol; 1999 Jul; 9(3):463-7. PubMed ID: 10416986
[TBL] [Abstract][Full Text] [Related]
55. Revisiting TP53 Mutations and Immunohistochemistry--A Comparative Study in 157 Diffuse Gliomas.
Takami H; Yoshida A; Fukushima S; Arita H; Matsushita Y; Nakamura T; Ohno M; Miyakita Y; Shibui S; Narita Y; Ichimura K
Brain Pathol; 2015 May; 25(3):256-65. PubMed ID: 25040820
[TBL] [Abstract][Full Text] [Related]
56. TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.
Mascelli S; Nozza P; Jones DT; Colin C; Pistorio A; Milanaccio C; Ravegnani M; Consales A; Witt O; Morana G; Cama A; Capra V; Biassoni R; Pfister SM; Figarella-Branger D; Garrè ML; Raso A
Oncotarget; 2016 Jul; 7(30):47918-47926. PubMed ID: 27374106
[TBL] [Abstract][Full Text] [Related]
57. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Wang Y; Kringen P; Kristensen GB; Holm R; Baekelandt MM; Olivier M; Skomedal H; Hainaut P; Tropé CG; Abeler VM; Nesland JM; Børresen-Dale AL; Helland A
Hum Mutat; 2004 Jul; 24(1):21-34. PubMed ID: 15221786
[TBL] [Abstract][Full Text] [Related]
58. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
[TBL] [Abstract][Full Text] [Related]
59. Mutations of the adenomatous polyposis coli and p53 genes in a child with Turcot's syndrome.
Barel D; Cohen IJ; Mor C; Stern S; Shapiro R; Shomrat R; Galanti Y; Legum C; Zaizov R; Avigad S
Cancer Lett; 1998 Oct; 132(1-2):119-25. PubMed ID: 10397462
[TBL] [Abstract][Full Text] [Related]
60. Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma.
Giannini C; Hebrink D; Scheithauer BW; Dei Tos AP; James CD
Neurogenetics; 2001 Jul; 3(3):159-62. PubMed ID: 11523567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
